Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - diltiazem hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - diltiazem hydrochloride -

United States - English - NLM (National Library of Medicine)

apotex corp. - diltiazem hydrochloride (unii: olh94387te) (diltiazem - unii:ee92bbp03h) - diltiazem hydrochloride 120 mg - dilt-xr [diltiazem hydrochloride extended-release capsules, usp (once-a-day dosage)] are indicated for the treatment of hypertension. diltiazem hydrochloride may be used alone or in combination with other antihypertensive medications, such as diuretics. dilt-xr [diltiazem hydrochloride extended-release capsules, usp (once-a-day dosage)] are indicated for the management of chronic stable angina. diltiazem hydrochloride is contraindicated in: (1) patients with sick sinus syndrome except in the presence of a functioning ventricular pacemaker; (2) patients with second or third degree av block except in the presence of a functioning ventricular pacemaker; (3) patients with hypotension (less than 90 mmhg systolic); (4) patients who have demonstrated hypersensitivity to the drug; and (5) patients with acute myocardial infarction and pulmonary congestion as documented by x-ray on admission.

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - diltiazem hydrochloride (unii: olh94387te) (diltiazem - unii:ee92bbp03h) - diltiazem hydrochloride 60 mg - diltiazem hydrochloride tablets are indicated for the management of chronic stable angina and angina due to coronary artery spasm. diltiazem is contraindicated in: - patients with sick sinus syndrome except in the presence of a functioning ventricular pacemaker - patients with second- or third-degree av block except in the presence of a functioning ventricular pacemaker - patients with hypotension (less than 90 mm hg systolic) - patients who have demonstrated hypersensitivity to the drug - patients with acute myocardial infarction and pulmonary congestion documented by x-ray on admission

United States - English - NLM (National Library of Medicine)

carilion materials management - diltiazem hydrochloride (unii: olh94387te) (diltiazem - unii:ee92bbp03h) - diltiazem hydrochloride 60 mg - diltiazem hydrochloride tablets usp are indicated for the management of chronic stable angina and angina due to coronary artery spasm. diltiazem is contraindicated in:

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - diltiazem hydrochloride, quantity: 360 mg - capsule, modified release - excipient ingredients: purified talc; methacrylic acid copolymer; povidone; tributyl acetylcitrate; sodium lauryl sulfate; diethyl phthalate; simethicone; maize starch; sucrose; titanium dioxide; brilliant blue fcf; potable water; gelatin; silicon dioxide - cardizem cd is indicated for the treatment of hypertension. cardizem cd is also indicated for the management of chronic stable angina (effort-associated angina) where there is no evidence of vasospastic or unstable angina. since the safety and efficacy of cd capsules in the management of unstable or vasospastic angina has not been substantiated, use of this formulation for these indications is not recommended.

Israel - English - Ministry of Health

teva israel ltd - diltiazem hydrochloride - tablets - diltiazem hydrochloride 30 mg - diltiazem - diltiazem - calcium channel blocker for the treatment of angina pectoris.

United States - English - NLM (National Library of Medicine)

ncs healthcare of ky, inc dba vangard labs - diltiazem hydrochloride (unii: olh94387te) (diltiazem - unii:ee92bbp03h) - diltiazem hydrochloride extended-release capsules (once-a-day dosage) are indicated for the treatment of hypertension. it may be used alone or in combination with other antihypertensive medications. diltiazem hydrochloride extended-release capsules (once-a-day dosage) are indicated for the management of chronic stable angina and angina due to coronary artery spasm. diltiazem is contraindicated in (1) patients with sick sinus syndrome except in the presence of a functioning ventricular pacemaker, (2) patients with second- or third-degree av block except in the presence of a functioning ventricular pacemaker, (3) patients with hypotension (less than 90 mm hg systolic), (4) patients who have demonstrated hypersensitivity to the drug, and (5) patients with acute myocardial infarction and pulmonary congestion documented by x-ray on admission.

New Zealand - English - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - diltiazem hydrochloride 60mg - film coated tablet - 60 mg - active: diltiazem hydrochloride 60mg excipient: colloidal silicon dioxide hypromellose lactose monohydrate magnesium stearate methyl hydroxybenzoate microcrystalline cellulose opadry quinoline yellow sunset yellow fcf - patients with moderate to severe angina pectoris due to atherosclerotic coronary artery disease or coronary artery spasm (vasospastic angina).

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - diltiazem hydrochloride 60mg;  ;  ;  ;   - film coated tablet - 60 mg - active: diltiazem hydrochloride 60mg         excipient: aluminium hydroxide gel hydrogenated castor oil lactose monohydrate magnesium stearate methacrylic acid copolymer opadry white y-1r-7000b purified talc